465
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density

, , , , , & show all
Pages 1341-1349 | Accepted 21 Mar 2007, Published online: 02 May 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Wei Luo, Jin Zhang, Ling Xu, Yao Zhou, Dan Xu, Qiuju Lv, Yi Xiao & Qin Yang. (2022) Use of zoledronic acid in antiosteoporosis treatment is associated with a decreased blood lipid level in postmenopausal women with osteoporosis: a cohort study in China. Postgraduate Medicine 134:4, pages 406-412.
Read now
M. J. Bolland, A. Grey & I. R. Reid. (2015) Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?. Climacteric 18:sup2, pages 22-31.
Read now

Articles from other publishers (51)

Chaiho Jeong, Jinyoung Kim, Jeongmin Lee, Yejee Lim, Dong-Jun Lim, Ki-Hyun Baek & Jeonghoon Ha. (2023) Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea. Journal of Clinical Medicine 12:21, pages 6904.
Crossref
Xiqian Huo, Robert Clarke, Jim Halsey, Rebecca Jackson, Amy Lehman, Richard Prince, Joshua Lewis, John A. Baron, Heikki Kroger, Reijo Sund & Jane Armitage. (2023) Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized Trials. Current Developments in Nutrition 7:3, pages 100046.
Crossref
Yuliya A. Kaminarskaya. (2022) Calcium and vitamin D supplements for the treatment and prevention of osteoporosis. Should it be widely used?. Clinical nutrition and metabolism 3:3, pages 167-176.
Crossref
Ian R Reid. (2022) EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: Osteoporosis management. European Journal of Endocrinology 187:4, pages R65-R80.
Crossref
Seung-Kwon Myung, Hong-Bae Kim, Yong-Jae Lee, Yoon-Jung Choi & Seung-Won Oh. (2021) Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials. Nutrients 13:2, pages 368.
Crossref
І. Ю. Головач. (2020) Contemporary Strategies for Prevention and Treatment of Osteoporosis: Role of Calcium and Vitamin D. Family medicine:4, pages 28-31.
Crossref
Ian R Reid. (2020) Osteoporosis: evidence for vitamin D and calcium in older people. Drug and Therapeutics Bulletin 58:8, pages 122-125.
Crossref
Ian R Reid & Mark J Bolland. (2020) Calcium and/or Vitamin D Supplementation for the Prevention of Fragility Fractures: Who Needs It?. Nutrients 12:4, pages 1011.
Crossref
Ian R Reid & Mark J Bolland. (2019) Controversies in medicine: the role of calcium and vitamin D supplements in adults. Medical Journal of Australia 211:10, pages 468-473.
Crossref
Agustin Cerani, Sirui Zhou, Vincenzo Forgetta, John A Morris, Katerina Trajanoska, Fernando Rivadeneira, Susanna C Larsson, Karl Michaëlsson & J Brent Richards. (2019) Genetic predisposition to increased serum calcium, bone mineral density, and fracture risk in individuals with normal calcium levels: mendelian randomisation study. BMJ, pages l4410.
Crossref
Ian R. Reid & Sarah M. Bristow. 2020. Bone Regulators and Osteoporosis Therapy. Bone Regulators and Osteoporosis Therapy 259 280 .
Iacopo Chiodini & Mark J Bolland. (2018) Calcium supplementation in osteoporosis: useful or harmful?. European Journal of Endocrinology 178:4, pages D13-D25.
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2018. Geriatric Diseases. Geriatric Diseases 371 381 .
N. C. Harvey, E. Biver, J.-M. Kaufman, J. Bauer, J. Branco, M. L. Brandi, O. Bruy?re, V. Coxam, A. Cruz-Jentoft, E. Czerwinski, H. Dimai, P. Fardellone, F. Landi, J.-Y. Reginster, B. Dawson-Hughes, J. A. Kanis, R. Rizzoli & C. Cooper. (2016) The role of calcium supplementation in healthy musculoskeletal ageing. Osteoporosis International 28:2, pages 447-462.
Crossref
Lukas Schwingshackl, Heiner Boeing, Marta Stelmach-Mardas, Marion Gottschald, Stefan Dietrich, Georg Hoffmann & Anna Chaimani. (2017) Dietary Supplements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis of Primary Prevention Trials. Advances in Nutrition 8:1, pages 27-39.
Crossref
Ian R. Reid, Sarah M. BirstowMark J. Bolland. (2017) Calcium and Cardiovascular Disease. Endocrinology and Metabolism 32:3, pages 339.
Crossref
Nages Nagaratnam, Kujan Nagaratnam & Gary CheukNages Nagaratnam, Kujan Nagaratnam & Gary Cheuk. 2017. Geriatric Diseases. Geriatric Diseases 1 11 .
I. R. Reid. (2016) Controversies in osteoporosis management. Internal Medicine Journal 46:7, pages 767-770.
Crossref
I. R. Reid. (2015) Efficacy, effectiveness and side effects of medications used to prevent fractures. Journal of Internal Medicine 277:6, pages 690-706.
Crossref
Jeri W. Nieves & Felicia Cosman. 2015. Nutrition and Bone Health. Nutrition and Bone Health 681 686 .
Joshua R Lewis, Simone Radavelli-Bagatini, Lars Rejnmark, Jian Sheng Chen, Judy M Simpson, Joan M Lappe, Leif Mosekilde, Ross L Prentice & Richard L Prince. (2015) The Effects of Calcium Supplementation on Verified Coronary Heart Disease Hospitalization and Death in Postmenopausal Women: A Collaborative Meta-Analysis of Randomized Controlled Trials. Journal of Bone and Mineral Research 30:1, pages 165-175.
Crossref
Elizabeth L. Barry, Leila A. Mott, Michal L. Melamed, Judith R. Rees, Anastasia Ivanova, Robert S. Sandler, Dennis J. Ahnen, Robert S. Bresalier, Robert W. Summers, Roberd M. Bostick & John A. Baron. (2014) Calcium Supplementation Increases Blood Creatinine Concentration in a Randomized Controlled Trial. PLoS ONE 9:10, pages e108094.
Crossref
J. M. Paik, G. C. Curhan, Q. Sun, K. M. Rexrode, J. E. Manson, E. B. Rimm & E. N. Taylor. (2014) Calcium supplement intake and risk of cardiovascular disease in women. Osteoporosis International 25:8, pages 2047-2056.
Crossref
P. Mosali, L. Bernard, J. Wajed, Z. Mohamed, M. Ewang, A. Moore, I. Fogelman & G. Hampson. (2014) Vitamin D Status and Parathyroid Hormone Concentrations Influence the Skeletal Response to Zoledronate and Denosumab. Calcified Tissue International 94:5, pages 553-559.
Crossref
Sarah M. Bristow, Mark J. Bolland, Graeme S. MacLennan, Alison Avenell, Andrew Grey, Greg D. Gamble & Ian R. Reid. (2013) Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials. British Journal of Nutrition 110:8, pages 1384-1393.
Crossref
Mark J. Bolland, Andrew Grey & Ian R. Reid. (2013) Calcium supplements and cardiovascular risk: 5 years on. Therapeutic Advances in Drug Safety 4:5, pages 199-210.
Crossref
Vicki McLaughlin, Katherine W Reeves & Elizabeth Bertone-Johnson. (2013) Fatty acid consumption and the risk of osteoporotic fracture. Nutrition Reviews 71:9, pages 600-610.
Crossref
Liang Zhu, Wei Zheng, Feng-Chao Zhao, Yi Guo, Bai-Yi Meng, Kai-Jin Guo & Hong-Tao Liu. (2013) A meta-analysis of bisphosphonates for periprosthetic bone loss after total joint arthroplasty. Journal of Orthopaedic Science 18:5, pages 762-773.
Crossref
Wei-Ping Ji, Xiao-Ling Wang, Miao-Qun Ma, Jun Lan & Hao Li. (2012) Prevention of early bone loss around the prosthesis by administration of anti-osteoporotic agents and influences of collared and non-collared femoral stem prostheses on early periprosthetic bone loss. European Journal of Orthopaedic Surgery & Traumatology 23:5, pages 565-571.
Crossref
Rajib K. Bhattacharya, Vaishali B. Patel & James L. Vacek. (2013) Calcium Affects on Vascular Endpoints (CAVE) Retrospective Cohort Trial. Open Journal of Endocrine and Metabolic Diseases 03:01, pages 75-79.
Crossref
S. Christodoulou, T. Goula, A. Ververidis & G. Drosos. (2013) Vitamin D and Bone Disease. BioMed Research International 2013, pages 1-6.
Crossref
J. Yates. (2012) A meta-analysis characterizing the dose–response relationships for three oral nitrogen-containing bisphosphonates in postmenopausal women. Osteoporosis International 24:1, pages 253-262.
Crossref
S. Bourke, M. J. Bolland, A. Grey, A. M. Horne, D. J. Wattie, S. Wong, G. D. Gamble & I. R Reid. (2012) The impact of dietary calcium intake and vitamin D status on the effects of zoledronate. Osteoporosis International 24:1, pages 349-354.
Crossref
Ian R. Reid. 2013. Nutritional Influences on Bone Health. Nutritional Influences on Bone Health 365 372 .
Ronald D. Emkey & Gregory R. Emkey. (2012) Calcium Metabolism and Correcting Calcium Deficiencies. Endocrinology and Metabolism Clinics of North America 41:3, pages 527-556.
Crossref
. (2012) Scientific Opinion on the Tolerable Upper Intake Level of calcium. EFSA Journal 10:7.
Crossref
Pilar Peris, Angeles Mart?nez-Ferrer, Ana Monegal, M. Jes?s Mart?nez de Osaba, Africa Muxi & Nuria Gua?abens. (2012) 25 hydroxyvitamin D serum levels influence adequate response to bisphosphonate treatment in postmenopausal osteoporosis. Bone 51:1, pages 54-58.
Crossref
T. Lin, S.-G. Yan, X.-Z. Cai & Z.-M. Ying. (2011) Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials. Osteoporosis International 23:6, pages 1823-1834.
Crossref
Joshua R Lewis, Kun Zhu & Richard L Prince. (2012) Adverse events from calcium supplementation: Relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation. Journal of Bone and Mineral Research 27:3, pages 719-722.
Crossref
Miguel Arrabal-Polo, Miguel Arrabal-Martin, Salvador Arias-Santiago & Armando Zuluaga-Gomez. (2012) Alendronate in patients with calcium nephrolithiasis and loss of bone mass. Open Medicine 7:4.
Crossref
Ian R. Reid, Mark J. Bolland, Philip N. Sambrook & Andrew Grey. (2011) Calcium supplementation: Balancing the cardiovascular risks. Maturitas 69:4, pages 289-295.
Crossref
I. R. Reid, M. J. Bolland, A. Avenell & A. Grey. (2011) Cardiovascular effects of calcium supplementation. Osteoporosis International 22:6, pages 1649-1658.
Crossref
Paul Lips, Roger Bouillon, Natasja M. Van Schoor, Dirk Vanderschueren, Sabine Verschueren, Natalia Kuchuk, Koen Milisen & Steven Boonen. (2010) REVIEW ARTICLE: Reducing fracture risk with calcium and vitamin D. Clinical Endocrinology 73:3, pages 277-285.
Crossref
Mark J. Bolland, Andrew B. Grey, Greg D. Gamble & Ian R. Reid. (2010) Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism 95:3, pages 1174-1181.
Crossref
S. Boonen, R. Kay, C. Cooper, P. Haentjens, D. Vanderschueren, F. Callewaert, K. Milisen & S. Ferrari. (2009) Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases. International Journal of Clinical Practice 63:12, pages 1792-1804.
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:6, pages 548-559.
Crossref
Alexandra Papaioannou, Courtney C. Kennedy, Andreas Freitag, George Ioannidis, John O'Neill, Colin Webber, Margaret Pui, Yves Berthiaume, Harvey R. Rabin, Nigel Paterson, Alphonse Jeanneret, Elias Matouk, Josee Villeneuve, Madeline Nixon & Jonathan D. Adachi. (2008) Alendronate Once Weekly for the Prevention and Treatment of Bone Loss in Canadian Adult Cystic Fibrosis Patients (CFOS Trial). Chest 134:4, pages 794-800.
Crossref
Patrick G Clay, Laura E Voss, Charlott Williams & Eric C Daume. (2008) Valid Treatment Options for Osteoporosis and Osteopenia in HIV-Infected Persons. Annals of Pharmacotherapy 42:5, pages 670-679.
Crossref
Charles-Joël Menkes. (2008) Lait et produits laitiers dans la prévention et le traitement des maladies par carence. Bulletin de l'Académie Nationale de Médecine 192:4, pages 739-747.
Crossref
. 2008. Orthopedic Traumatology - A Resident's Guide. Orthopedic Traumatology - A Resident's Guide 177 201 .
David Ip. 2008. Casebook of Orthopedic Rehabilitation. Casebook of Orthopedic Rehabilitation 111 117 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.